Why is Dr Agarwals Eye Hospital Ltd falling/rising?

Recent Price Movement and Market Context

The stock has demonstrated strong momentum in recent sessions, gaining for four consecutive days and delivering an 8.75% return over this period. On the day in question, it outperformed its sector by 3.11%, reaching an intraday high of ₹4,990, a 3.93% increase from the previous close. Despite some volatility, with an intraday low of ₹4,616.5, the overall trend remains positive. The weighted average price indicates that more volume was traded near the lower end of the day’s range, suggesting some profit-taking or cautious buying at elevated levels. However, the stock remains above its 5-day, 20-day, 50-day, and 200-day moving averages, signalling sustained upward momentum, although it is still below the 100-day moving average.

Strong Relative Performance Against Benchmarks

Over the past week, Dr Agarwals Eye Hospital Ltd’s shares have surged by 8.17%, contrasting sharply with the Sensex’s decline of 4.98%. Even over a one-month horizon, the stock posted a modest gain of 0.70%, while the benchmark index fell by 9.13%. Year-to-date, the stock’s decline of 8.78% is less severe than the Sensex’s 10.78% drop, indicating relative resilience. More impressively, the stock has delivered a 12.47% return over the last year, significantly outperforming the Sensex’s 2.71% gain. Its three-year and five-year returns stand at 411.67% and 1,282.19% respectively, dwarfing the benchmark’s 28.58% and 49.70% gains, underscoring the company’s strong growth trajectory and investor confidence over the longer term.

Fundamental Strength Driving Investor Interest

The company’s recent financial performance provides a solid foundation for the stock’s rise. Dr Agarwals Eye Hospital Ltd has reported positive results for four consecutive quarters, reflecting operational consistency and profitability. Its profit after tax (PAT) for the nine-month period stands at ₹53.86 crores, marking a robust growth rate of 39.32%. Operating profit to interest ratio has reached a high of 16.93 times, indicating strong earnings relative to debt servicing costs. Additionally, profit before tax excluding other income has surged by 76.00% to ₹20.68 crores in the latest quarter, signalling improving core business profitability.

The company’s operating profit has grown at an impressive annual rate of 83.03%, highlighting sustained expansion in earnings capacity. Return on capital employed (ROCE) is a healthy 16.6%, suggesting efficient use of capital to generate profits. The enterprise value to capital employed ratio of 4.7 indicates a fair valuation, especially when compared to peers, as the stock currently trades at a discount relative to the average historical valuations of its sector counterparts.

Over the past year, the stock’s 12.47% return has been accompanied by a 35.8% increase in profits, resulting in a price-to-earnings-to-growth (PEG) ratio of 1.1. This metric suggests that the stock’s price growth is broadly in line with its earnings growth, supporting a balanced valuation perspective for investors.

Consistent Outperformance and Market Position

Dr Agarwals Eye Hospital Ltd has consistently outperformed the broader market, including the BSE500 index, over the last three annual periods. This track record of delivering superior returns alongside strong profit growth has likely contributed to sustained investor confidence and the recent positive price action. Despite a recent decline in delivery volumes by over 90% compared to the five-day average, the stock remains sufficiently liquid for typical trade sizes, ensuring ease of entry and exit for investors.

Conclusion: Why the Stock is Rising

The rise in Dr Agarwals Eye Hospital Ltd’s share price on 12-Mar can be attributed to a confluence of strong quarterly earnings growth, healthy long-term profitability, and consistent outperformance relative to market benchmarks. The company’s ability to sustain high operating profit growth and maintain a favourable ROCE while trading at a discount to peers has made it an attractive proposition for investors. The recent four-day rally and outperformance against the sector further underscore positive market sentiment. While some caution is warranted due to falling investor participation and volume concentration near lower price levels, the overall fundamentals and valuation metrics support the current upward trend in the stock price.

Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →